Advertisement
Screener

EDITAS MEDICINE, INC. (EDIT) Auditor

EDITAS MEDICINE, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-09: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2025-03-05: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-02-28: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-02-22: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-092025-12-31Ernst & Young LLP42Boston, MassachusettsNo
2025-03-052024-12-31Ernst & Young LLP42Boston, MassachusettsNo
2024-02-282023-12-31Ernst & Young LLP42Boston, MassachusettsYes
2023-02-222022-12-31Ernst & Young LLP42Boston, MassachusettsYes
2022-02-242021-12-31Ernst & Young LLP42Boston, MassachusettsYes
2021-02-262020-12-31Ernst & Young LLPBoston, MassachusettsYes
2020-02-262019-12-31Ernst & Young LLPBoston, Massachusetts
2019-03-012018-12-31Ernst & Young LLPBoston, Massachusetts
2018-03-082017-12-31Ernst & Young LLPBoston, Massachusetts
2017-03-032016-12-31Ernst & Young LLPBoston, Massachusetts
2016-03-302015-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
REGENXBIO Inc. (RGNX)United States$0.477B-3.30